Catalent Pharma Solutions

Welcome to Catalent Pharma Solutions, Australia's premier institution for pharmaceutical, biotech, and consumer health innovations. Located at 7 Inman Road, Cromer, our establishment serves as a vital point of interest for those seeking superior healthcare products that enhance and improve people's lives.

As the leading Contract Development and Manufacturing Organization (CDMO) partner in the industry, Catalent is dedicated to helping our clients develop, deliver, and supply cutting-edge gene therapies, medications, and healthcare solutions. We are proud to be the go-to resource for pharmaceutical companies, biotech startups, and consumer health innovators, providing them with the expertise and support needed to bring their products to market successfully.

Our commitment to advancing the field of gene therapy is exemplified by the expansion of our UPTEMPO℠ AAV platform. This innovative platform allows for the accelerated development of gene therapies, revolutionizing the treatment options available to patients.

In collaboration with Sarepta, a leading biopharmaceutical company, Catalent has further expanded our strategic manufacturing partnership. This includes a commercial supply agreement for a groundbreaking gene therapy candidate for Duchenne Muscular Dystrophy. Through this collaboration, we aim to make significant strides in improving the lives of those affected by this debilitating condition.

At Catalent, we understand that our success is driven by our people. That is why we are thrilled to announce the appointment of Lisa Evoli as our Senior Vice President and Chief Human Resources Officer. With her expertise and leadership, we are confident in our ability to cultivate a talented and diverse workforce that will continue to drive our organization forward.

For emerging biotech companies, we have developed a comprehensive CDMO playbook that outlines the strategies and considerations necessary for successful scaling. With our guidance, these companies can navigate the complex landscape of drug development and manufacturing, ensuring their products reach the market efficiently and effectively.

Our expertise extends to all stages of drug development, including the critical early stages. We provide valuable insights and CMC (Chemistry, Manufacturing, and Controls) considerations that are essential for successful early drug development. By partnering with Catalent, companies can optimize their formulations and minimize risks, setting them up for success in clinical trials and beyond.

In the realm of solid dose manufacturing, we utilize modern modeling tools to enhance efficiency and quality. These tools allow us to develop optimized formulations for small molecule medications, ensuring the highest level of efficacy and patient safety.

For fast-tracked development programs, our softgel technology is the ideal solution. This versatile dosage form allows for rapid development and commercialization, enabling our clients to bring their products to market quickly and efficiently.

Patient compliance is a crucial aspect of any medication, and at Catalent, we are dedicated to exploring patient-centric solutions. One such solution is orally disintegrating tablets, which offer convenience, ease of administration, and improved patient adherence. Our experts in dosage form design can assist in developing these innovative tablets, ensuring patient satisfaction and therapeutic success.

At Catalent Pharma Solutions, we are proud to be at the forefront of healthcare innovation in Australia. With our expertise, cutting-edge technologies, and dedication to improving people's lives, we are the trusted partner for all your pharmaceutical, biotech, and consumer health needs. Contact us today to learn more about how we can support your organization's goals and aspirations.